If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
540.00    -11.00 (-2.00%)
Bid:
542.00
Ask:
545.00
Spread: 3.00 (0.554%)
Market Cap: £995.07m
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Holding(s) in Company

6 Aug 2008 15:46

RNS Number : 7954A
Volex Group PLC
06 August 2008
 
TR-l: NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

volex group plc
 
2. Reason for the notification: (please state Yes/No):
 
An acquisition or disposal of voting rights:
 
An acquisition or disposal of financial instruments, which may result in the acquisition of shares already issued to which voting rights are attached:
 
An event changing the breakdown of voting rights:
 
Other (please specify)
 
THE GOLDMAN SACHS GROUP, INC IS NO LONGER INCLUDING IN ITS AGGREGATE NOTIFIABLE HOLDING THE POSITION HELD BY GOLDMAN, SACHS & CO., A WHOLLY OWNDED DIRECT SUBSIDIARY OF GOLDMAN SACHS GROUP INC, ACTING AS CUSTODIAN FOR ITS CUSTOMERS, BECAUSE OF THE APPLICATION OF THE CUSTODIAN EXEMPTION IN DTR 5.1.3R(2) TO THOSE POSITIONS.
 
3. Full name of the person(s) subject to the notification obligation:
 
the goldman sachs group, inc.
 
4. Full name of shareholder(s) (if different from 3.):
 
GOLDMAN SACHS INTERNATIONAL
 
5. Date of the transaction and date on which the threshold is crossed or reached:
 
31 JULY 2008
 
6. Date on which issuer notified:
 
5 AUGUST 2008
 
7. Threshold(s) that is/are crossed or reached:
 
8%
 
8. Notified details:
 
A: Voting rights attached to shares
 
Class /type of shares
Situation Previous to the Triggering
Transaction
Resulting situation after the Triggering Transaction 
If possible using the
ISIN CODE
Number of
Shares
Number of voting
Rightsviii
Number
 of
shares
Number of voting
Rightsix
% of voting Rights
 
 
 
Directx
Directxi
Indirect
Direct
Indirect
 
 
 
 
GB0009390070
11,945,802
20.99%
 
4,497,827
-
7.90%
-
 
 
 
 
 
 
 
 
 
 
B: Financial Instruments
 
 Resulting situation after the triggering transactionxii
 
Type of
financial
instrument
Expiration Date xiii
 
Exercise
Conversion Period
/ Date xiv
Number of voting
Rights that may be
Acquired if the instrument is exercised/converted.
 
% of voting
rights
-
-
-
-
-
 
 
Total (A+B)
 
Number of voting rights
% of voting rights
 
4,497,827
 
7.90%
 
 
 
 
 
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable xv
The interest in 4,497,827 shares arose from a beneficial interest held by Goldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. These shares are, or will be, registered at CREST in account CREPTEMP.
 
Proxy Voting:
 
10. Name of the proxy holder:
 
not applicable
 
11. Number of voting rights proxy holder will cease to hold:
 
not applicAble
 
12. Date on which proxy holder will cease to hold voting rights:
 
not applicAble
 
13. Additional information
 
not applicAble
 
14. Contact name:
 
wendy tate
company secretary
 
15. Contact telephone number:
 
01925 830101
END
 
 
 
 
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBSGDIUSGGGIL
Date   Source Headline
25th Jun 20267:00 amRNSPreliminary Group Results FY2026
25th Jun 20267:00 amRNSUpdate on Move to the Main Market
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.